title: Persistence of gadolinium contrast enhancement in CSF: a possible harbinger of gadolinium neurotoxicity?
authors.forename: F K
authors.initials: FK
authors.lastname: Hui
authors.forename: M
authors.initials: M
authors.lastname: Mullins
mesh_terms: D001921:Brain / Q000473:pathology*; D002555:Cerebrospinal Fluid / Q000166:cytology*; D003287:Contrast Media / Q000009:adverse effects*; D005682:Gadolinium / Q000009:adverse effects*; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000009:adverse effects*; D020258:Neurotoxicity Syndromes / Q000175:diagnosis* / Q000209:etiology*; D009498:Neurotoxins / Q000009:adverse effects; D018570:Risk Assessment
chemical_list: D003287:Contrast Media; D009498:Neurotoxins; D005682:Gadolinium